TD Cowen Insights

Recorded on 7/29/20 In the latest episode of Nightmare on K Street, Chris Krueger of Cowen's Washington Research Group tackles Phase IV coronavirus relief prospects and inventories potential 2020 election game-changers. Cowen’s Washington Research Group lives at the intersection of Wall Street and K Street. Their analysts cover key sectors of the U.S. economy and can expertly translate how politics and markets impact one another in a substantive, engaging fashion. This sharp new podcast series will brief you on the latest from the White House to Capitol Hill, and across the geopolitical landscape — faster than a speeding Acela. Disclosures: http://bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure

Recorded 07/09/20 On this episode, we interview Dr. Erik Mittra, an associate professor of diagnostic radiology at the Oregon Health & Science University. Dr. Mittra has a particular interest in targeted radioisotope therapies in oncology and he is a nationally recognized expert in this area. Podcast episode hosted by Cowen's managing director and senior research analyst covering emerging growth biotechnology companies, Boris Peaker. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure

Recorded on 07/07/20 WRG’s Chris Krueger chats with JAG Public Affairs’ Jonathan Grella to discuss COVID-19 relief legislation, the latest 2020 election analysis (including Biden’s Veepstakes), as well as Supreme Court retirement rumors. Cowen’s Washington Research Group lives at the intersection of Wall Street and K Street. Their analysts cover key sectors of the U.S. economy and can expertly translate how politics and markets impact one another in a substantive, engaging fashion. This sharp new podcast series will brief you on the latest from the White House to Capitol Hill, and across the geopolitical landscape — faster than a speeding Acela. Disclosures: http://bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure

Recorded on 06-22-20 In this episode, we talk about the role of technology in the provider setting. Technology is playing an increasingly important role in optimizing the workflows and reducing the administrative burdens of providers. And to help us explore this topic is Bill Korn, CFO of MTBC, a health information technology company that helps customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. Podcast episode hosted by Cowen's Health Care Technology Analyst Charles Rhyee. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure

Recorded on 06-22-20 Join us as we speak Suresh Katta, founder and CEO, along with Greg Simpson VP and Head of Marketing, of Saama Technologies, a clinical data analytics company that leverages AI to integrate, curate and animate structure, unstructured and real-world data to deliver actionable insights for biopharma. In this episode, we talk about AI-powered data and analytics in clinical development. In the digital age, data and analytics are being applied to just about everything, and nowhere more than in drug development. The biopharma space is always looking for ways to accelerate and optimize the clinical development process. Podcast episode hosted by Cowen's Healthcare Technology Analyst Charles Rhyee. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure

Recorded on 06-19-20 Join us as we speak with CEO of Glooko, Russ Johannesson and discuss the future of digital diabetes care. Podcast episode hosted by Cowen's Health Care Analyst, Ryan Blicker, who covers diabetes devices, an industry with exciting long term secular growth. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure

Recorded on 06-18-20 In this episode, we talk about data. The explosion of data in the digital age has changed how we do just about everything, and that holds true for healthcare as well. The biopharma industry, which has always valued and sought out new forms of data has increasingly started looking outside the controlled environment of clinical trials to find data from the real world. One newer form of real-world evidence is everyday behavior data. And to help us explore this topic is Deborah Kilpatrick, CEO of Evidation Health, a new kind of health and measurement company that focuses on capturing and measuring everyday behavior data, which is proving to be an exceptionally powerful lens on health. Podcast episode hosted by Cowen's Health Care Technology Analyst Charles Rhyee. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure

Recorded on 06-18-20 In this episode, we continue the discussion around digital therapeutics with David Klein, co-Founder and CEO of Click Therapeutics, which develops software as a prescription medical treatment using cognitive and neurobehavioral mechanism to enable change within individuals. Podcast episode hosted by Cowen's Health Care Technology Analyst Charles Rhyee. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure

In this episode, Anand Iyer, Chief Strategy Officer of Welldoc, discusses the development and outcomes of Welldoc's BlueStar, a mobile prescription therapy for type 2 diabetes. They explore the potential for reversing diabetes, improving diabetes care through technology and data analysis, and the challenges of commercializing digital therapeutics. They also touch on the opportunities for improving healthcare through digital tools and data insights.